Avid Bioservices Inc (CDMO)
12.21
+0.01
(+0.08%)
USD |
NASDAQ |
Nov 14, 12:17
Avid Bioservices Free Cash Flow: -11.45M for July 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| July 31, 2024 | -11.45M |
| April 30, 2024 | -20.85M |
| January 31, 2024 | -38.50M |
| October 31, 2023 | -55.94M |
| July 31, 2023 | -92.96M |
| April 30, 2023 | -90.52M |
| January 31, 2023 | -92.40M |
| October 31, 2022 | -88.99M |
| July 31, 2022 | -47.76M |
| April 30, 2022 | -46.95M |
| January 31, 2022 | -9.279M |
| October 31, 2021 | 8.002M |
| July 31, 2021 | 12.94M |
| April 30, 2021 | 21.32M |
| January 31, 2021 | 9.865M |
| October 31, 2020 | 4.737M |
| July 31, 2020 | 1.759M |
| April 30, 2020 | 2.015M |
| January 31, 2020 | 5.149M |
| October 31, 2019 | 3.941M |
| July 31, 2019 | -7.963M |
| April 30, 2019 | -13.10M |
| January 31, 2019 | -18.03M |
| October 31, 2018 | -23.12M |
| July 31, 2018 | -24.81M |
| Date | Value |
|---|---|
| April 30, 2018 | -29.78M |
| January 31, 2018 | -42.78M |
| October 31, 2017 | -46.22M |
| July 31, 2017 | -37.21M |
| April 30, 2017 | -42.80M |
| January 31, 2017 | -36.85M |
| October 31, 2016 | -35.21M |
| July 31, 2016 | -48.34M |
| April 30, 2016 | -48.47M |
| January 31, 2016 | -48.53M |
| October 31, 2015 | -49.45M |
| July 31, 2015 | -49.40M |
| April 30, 2015 | -45.07M |
| January 31, 2015 | -45.14M |
| October 31, 2014 | -42.07M |
| July 31, 2014 | -34.85M |
| April 30, 2014 | -29.01M |
| January 31, 2014 | -27.17M |
| October 31, 2013 | -25.48M |
| July 31, 2013 | -29.64M |
| April 30, 2013 | -21.78M |
| January 31, 2013 | -26.08M |
| October 31, 2012 | -28.06M |
| July 31, 2012 | -28.09M |
| April 30, 2012 | -37.43M |
Free Cash Flow Range, Past 5 Years
-92.96M
Minimum
Jul 2023
21.32M
Maximum
Apr 2021
-27.88M
Average
-11.45M
Median
Jul 2024
Free Cash Flow Benchmarks
| MEI Pharma Inc | -50.48M |
| Altimmune Inc | -71.48M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.68M |
| Cash from Investing (Quarterly) | -1.311M |
| Cash from Financing (Quarterly) | 0.266M |
| Free Cash Flow Per Share (Quarterly) | -0.0784 |
| Free Cash Flow to Equity (Quarterly) | -5.265M |
| Free Cash Flow to Firm (Quarterly) | -2.537M |
| Free Cash Flow Yield | -1.48% |